Gsk GSK
NYSE GSK
$52.41 +0.45 (+0.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gsk (GSK) Net Income - Minority (2009 - 2017)

Gsk (GSK) posted quarterly Net Income - Minority of -$647.9 million for Q4 2017, up 30.79% year-over-year from -$495.4 million in Q4 2016, and up 30.79% quarter-over-quarter from -$936.1 million in Q4 2016.

Gsk (GSK) Net Income - Minority (2009 - 2017) Analysis & Trends

Gsk's Net Income - Minority history runs 9 years deep, the most recent figure standing at -$647.9 million for Q4 2017.

  • In Q4 2017, Net Income - Minority rose 30.79% year-over-year to -$647.9 million; the TTM figure through Dec 2017 stood at -$647.9 million (up 30.79% YoY), while the FY2017 annual figure was -$628.7 million, up 38.46% from the prior year.
  • Net Income - Minority for Q4 2017 stood at -$647.9 million, up from -$936.1 million in the prior quarter.
  • The five-year high for Net Income - Minority was $63.7 million in Q4 2015, with the low at -$936.1 million in Q4 2016.
  • The 5-year median for Net Income - Minority is -$254.2 million (2013), against an average of -$383.7 million.
  • The sharpest annual moves came in 2015 and 2016: Net Income - Minority jumped 144.2% in 2015, then tumbled 1568.82% in 2016.
  • Gsk's Net Income - Minority stood at -$254.2 million in 2013, then jumped by 43.28% to -$144.2 million in 2014, then surged by 144.2% to $63.7 million in 2015, then slumped by 1568.82% to -$936.1 million in 2016, then jumped by 30.79% to -$647.9 million in 2017.
  • Business Quant data shows GSK's Net Income - Minority at -$647.9 million in Q4 2017, -$936.1 million in Q4 2016, and $63.7 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2017 -647.90 Mn
Dec 31, 2016 -936.15 Mn
Dec 31, 2015 63.73 Mn
Dec 31, 2014 -144.18 Mn
Dec 31, 2013 -254.19 Mn
Dec 31, 2012 -239.27 Mn
Dec 31, 2011 -6.29 Mn
Dec 31, 2010 -18.96 Mn
Dec 31, 2009 -6.53 Mn
Mar 31, 2009 -37.36 Mn